Here we go ladies and Gentlemen this is what a lot of us have been waiting for- the all important preliminary COVID data out of the Indian and American trials.
I'm expecting the results to be nothing short of groundbreaking. With all of the evidence out their surrounding a cough signature associated with COVID it remains in my mind highly likely that we can identify this with significant accuracy and the most important part - - - rule out other respiratory ailments due to our extensive library of signatures that the company has collected over several years. This is the important part of the puzzle that many other players could not obtain. This will determine with very high levels of accuracy if the individual actually has COVID-19 or NOT!!!
Yes this could be VERY, VERY exciting folks and look at the end of the day if it is and the share price jumps up dramatically at least there will be less dilution if a capital raise is required as I am sure we need some cash but perhaps ResApp holding this potential Ace up their sleeve may be able to induce a significant pharmaceutical player to form some sort of partnership agreement and upfront cash injection this is what I'm hoping for rather than dilution.... but I won't be complaining if we have to raise capital above $0.20 cents!!!
With covid-19 infection rates trending upwards in most Australian states and territories, as winter is right around the corner, the BA.2, which I believe from reports I have heard on the news lately is a sub variant of The omicron Strain. This is a dominant strain in 18 countries now. This means we in a new wave unfortunately with 20,000 cases alone recorded on Wednesday the 16th of March in New South Wales....
Some people even on these threads have become so complacent thinking that COVID-19 is over it is far from over unfortunately. This company may have a very useful solution that will be cost-effective, easy to scale, faster to produce results and better for the environment. No need to spend a decent sum of money on RAT tests ANYMORE ( if we have accurate results) the savings for families will be a welcoming sign of relief particularly with the cost of living these days going through the roof just looked at the petrol prices!! ResApp's COVID-19 detection could be more accurate the rodent (RAT).. if this is the case I see governments switching to our technology.. Get a RAP test and then if proven positive follow up with a PCR. we could get a lot of free publicity shortly as well. A potential emergency clearance application to the FDA could also be on the cards!! This all bodes well for our existing core technology the DX!!
All the very best to everybody here. We all deserve to be successful particularly after all of the ups and downs that we have had to edure over the years!!
Cheers
Red bar
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-24
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online